• Profile
Close

Intraoperative dexmedetomidine attenuates norepinephrine levels in patients undergoing transsphenoidal surgery: A randomized, placebo-controlled trial

BMC Anesthesiology May 06, 2020

Kang RA, Jeong JS, Ko JS, et al. - Researchers examined if dexmedetomidine could reduce stress responses in cases undergoing endoscopic transnasal transseptal transsphenoidal surgery. Continuous infusion of 0.9% saline (n = 23) or dexmedetomidine (n = 23) was administered to 46 cases. Before surgery and at the end of drug infusion assessment of serum levels of epinephrine, norepinephrine, and glucose was done. Outcomes revealed reduction in norepinephrine release and rescue analgesic requirement in correlation with intraoperative dexmedetomidine administration. Hence, in patients undergoing transnasal transseptal transsphenoidal surgery, dexmedetomidine might have utility as an anesthetic adjuvant.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay